Within the pharmaceutical industry, discussions of product quality and safety often prioritise the active pharmaceutical ingredient (API). Yet APIs are only part of the overall formulation. The majority of most medicines, whether oral, injectable or topical, consists of excipients — substances that are officially designated as “inactive” but which perform a wide range of critical functions.
The Critical Role of Excipients
Whilst excipients are designated as “inactive”, they are far from inert. Their role extends well beyond acting as simple carriers or bulking agents. Depending on the formulation, they can:
- Enhance solubility and bioavailability of APIs
- Stabilise formulations, ensuring consistent efficacy throughout shelf life
- Control drug release profiles, including modified or sustained release
- Improve patient acceptability, through taste masking or texture
Without excipients, many APIs would be unusable in practice.
Ethanol as a Multifunctional Excipient
Among the most widely used excipients is ethanol (ethyl alcohol, alcohol). Ethanol provides a unique combination of physicochemical properties, making it suitable for diverse pharmaceutical applications:
- Solvent: facilitating dissolution of poorly soluble APIs in oral liquids, injectables, and inhalers
- Antimicrobial preservative: providing bactericidal and fungicidal activity in oral solutions
- Processing aid: utilised in extraction processes, crystallisation, and coating operations
Because ethanol is employed across multiple formulation types and production stages, the quality and consistency of supply are of particular importance.
Risks Associated with Non-GMP Ethanol
Industrial or technical grades of ethanol are produced in very high volumes, primarily for use in fuels or chemical manufacturing. These grades are not manufactured under Good Manufacturing Practice (GMP) or equivalent standards and may contain impurities, variable water content, or cross-contamination from non-pharmaceutical processes.
The use of non-GMP ethanol in pharmaceutical manufacture introduces significant risks:
- Patient safety: exposure to toxic contaminants or variable excipient composition
- Regulatory non-compliance: failure to meet pharmacopoeial requirements
- Batch rejection or recall: due to excipient-related contamination
- Reputational and commercial risk: undermining trust in the finished product
Why GMP Certification Matters
GMP certification provides assurance that excipients are manufactured under systems that ensure:
- Consistency of quality and supply
- Compliance with pharmacopoeial specifications (BP, Ph. Eur., USP, JP)
- Documented traceability from raw materials through to final packaging
- Alignment with global regulatory expectations (MHRA, EMA, FDA)
These principles are extended to excipients through USP General Chapter <1078> guidelines. The EXCiPACT GMP certification scheme takes this a step further, providing independent verification and reducing the audit burden for finished dose manufacturers.
Excipients are not “inactive” when it comes to product performance, regulatory compliance, and ultimately, patient safety. Ethanol exemplifies this reality: its widespread use and multifunctional role make GMP certification essential to ensure consistency, safety and trust.
Treating ethanol — and all excipients — with the same rigour as APIs is not only prudent, it is a baseline expectation for modern pharmaceutical manufacturing.
Explore Kimia’s GMP-certified ethanol solutions and discover how we support pharmaceutical manufacturers in meeting the highest global quality standards.
